• United Kingdom

Accepting PhD Students

1988 …2019
If you made any changes in Pure these will be visible here soon.

Research Output 1988 2019

Filter
Chapter
2016

New avenues for drug delivery in Leishmania: using treatment of visceral leishmaniasis with amphotericin B as an exemplar.

Carter, K. & Mullen, A., 20 Dec 2016, (Accepted/In press) Drug Discovery in Leishmaniasis. 15 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Visceral Leishmaniasis
Leishmania
Amphotericin B
Drug Delivery Systems
Pharmaceutical Preparations
2006

Translation of an experimental oral vaccine formulation into a commercial product.

Carter, K., Ferro, V., Alexander, J. & Mullen, A., 2006, Methods.. Vol. 38. p. 65-68 4 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Vaccines
Research Personnel
Intellectual Property
Influenza Vaccines
Contracts
2000

Non-ionic surfactant vesicles for the treatment of visceral leishmaniasis

Mullen, A. & Carter, K., 23 Feb 2000, Synthetic surfactant vesicles: niosomes and other non-phospholipid vesicular systems. Uchegbu, L. F. (ed.).

Research output: Chapter in Book/Report/Conference proceedingChapter

Surfactant

Non-Ionic Surfactant Vesicles for the Treatment of Visceral Leishmaniasis.

Mullen, A., Carter, K. & Baillie, A., 23 Feb 2000, Synthetic Surfactant Vesicles: Niosomes and Other Non-Phospholipid Vesicular Systems. Uchegbu, I. F. (ed.). Amsterdam , 6 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

1992
1 Citation (Scopus)

Pharmaco-disposition of the antileishmanial drug, sodium stibogluconate after the administration in the free and liposomal forms.

Collins, M., Carter, K. C. & Baillie, A. J., 30 Sep 1992, Microencapsulation of drugs. Whateley, T. (ed.). Switzerland , Vol. 1. p. 169-176 8 p. (Drug targeting and delivery; vol. 1).

Research output: Chapter in Book/Report/Conference proceedingChapter

1989

Clearance of Leishmania donovani from the liver of BALB/c mice results in local resistance to re-infection.

Carter, K. C., Baillie, A. J., Alexander, J. & Dolan, T. F., 1989, Leishmaniasis: the current status and new strategies for control. Boston: Springer Science + Business Media, Vol. 171. p. 993-999 7 p. (NATO-ASI Series A; vol. 171).

Research output: Chapter in Book/Report/Conference proceedingChapter

Leishmania donovani
Liver
Infection
Drug Therapy
Visceral Leishmaniasis

Relapse in Kala Azar: failure of sodium stibogluconate to clear parasites from organs other than the liver?

Carter, K. C., Alexander, J., Baillie, A. J. & Dolan, T. F., 1989, Leishmaniasis: the current status and new strategies for control. Hart, D. T. (ed.). Boston: Springer Science + Business Media, Vol. 171. p. 721-727 7 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Antimony Sodium Gluconate
Visceral Leishmaniasis
Treatment Failure
Parasites
Recurrence

The limitations of carrier mediated sodium stibogluconate chemotherapy in the BALB/c mouse model of visceral leishmaniasis.

Carter, K., Dolan, T. F., Alexander, J. & Baillie, A., 1989, Liposomes in the therapy of infectious diseases and cancer. Lopez-Berestein, G. & Fidler, I. (eds.). p. 215-225 11 p.

Research output: Chapter in Book/Report/Conference proceedingChapter